|
|
|
|
|
|
|
|
|
|
abstract
CA125 dominated performance for ovarian cancer early detection amongst four serum biomarkers evaluated in EPIC study pre-diagnostic serum, elevating on average 3 years prior to detection. Adding HE4 provided only marginal improvement. This natural history supports annual testing for early detection and highlights the importance of biomarker discovery complementing CA125.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.